Biogen (BIIB)

Investing Cash Flow

-$3.84B

Quarterly · Period ending: · USD

BIIB logo

BIIB Investing Cash Flow

Latest reported-$3.84B
BIIB Quarterly Cash from Investing ($2.10M → -$3.84B)
High-resolution chart · PNG

BIIB investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-3,839,200,000
-209,500,000
-1,231,700,000
-35,100,000
-57,000,000
-47,300,000
-18,600,000
-1,181,100,000
466,500,000
-66,000,000
-644,200,000
-1,739,700,000
-752,000,000
-952,800,000
-140,900,000
1,684,400,000
693,500,000
-648,000,000
-112,700,000
-233,600,000
-152,700,000
-64,700,000
-166,400,000
-52,400,000
-832,700,000
442,900,000
708,400,000
-365,900,000
-110,800,000
238,800,000
-1,625,300,000
-619,100,000
-1,148,500,000
1,346,600,000
-769,500,000
-1,246,800,000
-202,600,000
-744,200,000
-581,700,000
36,200,000
-736,100,000
-1,203,200,000
-1,807,529,000
-990,000,000
-1,253,300,000
-502,800,000
-378,278,000
-540,564,000
-630,127,000
5,993,000
-709,976,000
-324,392,000
-726,241,000
155,941,000
-375,454,000
-522,390,000
-53,116,000
618,000
-389,532,000
-587,177,000
-546,790,000
-126,795,000
-518,622,000
-69,754,000
683,964,000
249,737,000
382,622,000
-474,433,000
-211,514,000
-91,706,000
-465,757,000
-99,470,000
-250,223,000
449,577,000
-616,635,000
-66,649,000
564,094,000
-167,382,000
-63,678,000
121,491,000
-385,374,000
-272,212,000
-70,944,000
-534,294,000
1,027,693,000
-4,714,000
-199,793,000
-165,928,000
299,203,000
-315,910,000
-224,757,000
-48,260,000
-33,382,000
-94,343,000
-108,013,000
-48,398,000
-110,898,000
-22,201,000
-46,021,000
-68,605,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.